The University of Michigan Program for Clinical Research in Dermatology (PCRiD or CPU) provides clinical research opportunities for patients seeking new treatment options, and for healthy volunteers seeking to advance medical discovery. Located together with our dermatology clinics at the A. Alfred Taubman Healthcare Center, our program is committed to furthering the knowledge and understanding of dermatologic conditions and treatments.
We conduct all phases (I-IV) of clinical and therapeutic research trials for pharmaceutical companies, and are engaged in research studies supported by the National Institutes of Health and other programs. Our physicians and researchers have expertise across a wide range of dermatologic areas. Our clinical research and basic science teams work seamlessly to translate our findings into new or improved therapies and have assisted the development of many dermatologic drugs that are in use today.
For more information about ongoing clinical trials, please contact us at (734) 232-0562. Current areas of study include:
- Atopic Dermatitis
- Autoimmune skin diseases
- Inflammatory skin
- Normal skin
- Palmoplantar Pustulosis
- Prurigo nodularis
- Stretch marks (striae distensae)
PCRID maintains a robust core of experienced staff, who provide study coordination, budget development, regulatory expertise, bio statistical analysis, and more. Our clinical research program has produced pioneering discovery published in the New England Journal of Medicine, Nature, Nature Medicine, the Journal of Clinical Investigation, the Journal of the American Medical Association, the Journal of Experimental Medicine, and in many top dermatological journals.